Retatrutide in France: availability, trials and risks
Retatrutide in France: check availability, trials and the risks of online sales. For retatrutide in Europe, distinguish access from approval.
Read the analysisSupplements
Identify supplements that are really worth your money: independent analyses covering studied doses, side effects and limits of the evidence, without marketing jargon.
Recent features
5-HTP (Griffonia): effects, risks and interactions you need to know
Griffonia risks: serotonin syndrome, SSRIs, opposite effects and contraindications. French 5-HTP status and ANSES/EFSA opinions checked.
Ipamorelin and CJC-1295: growth peptides, dosing and risks
Ipamorelin and CJC-1295: measured effects, DAC, no validated stack dosage, French regulatory status and a permanent anti-doping ban.
Betaine HCl: reflux, evidence, dosage and risks
Does betaine HCl really help with reflux or hypochlorhydria? A review of the studies, the burning test, pepsin and the risks.
Lithium and Alzheimer’s: did the LATTICE trial really work?
The LATTICE trial, mechanisms, limitations and risks: what lithium shows in Alzheimer’s and why orotate does not justify self-medication.
Natural nootropics: 10 options ranked by evidence
What is a nootropic? Ten natural options, racetams, ADHD medications and stacks compared by evidence, risks and status in France.